InsiderClue
Insiders · Profile

Coiante Scott M

SVP, Chief Financial Officer at Aprea Therapeutics. Filing since 7 Oct 2019. CIK 0001608536

Company
Date
Role
Action
Shares
Amount
Of holding
APRE Aprea Therapeutics, Inc.
7 Oct 2019
SVP, Chief Financial Officer
Bought
2,500
$37.50K
opened
1 decision on file.